Faizel Patel – 02/08/2021
University of KwaZulu-Natal Professor Colleen Aldous says that despite some scientists saying that there is a lack of evidence on Ivermectin’s efficacy to treat the disease, it does hold clinical benefits.
Aldous was speaking to Radio Islam about the debate over the use of Ivermectin to treat COVID-19.
Aldous says while COVID-19 vaccines are the only way to get the country out of the pandemic, the anti-parasitic drug Ivermectin can help sick patients.
Aldous says she does not agree with researchers that Ivermectin does not have a significant effect on the Coronavirus.
“They are waiting for one large single randomised control trial. I’ve looked at the entire evidence beyond randomised control trials and I’ve seen that there’s a lot of research that’s being done in a laboratory to show the safety and efficacy of Ivermectin. There’s a lot of evidence on the ground with doctors having prescribed it now for six months since it was made legal to use in South Africa and they are having really good results.”
Aldous says the primary importance of Ivermectin is treating sick people and treating them very early.
“So the minute they know they’ve got COVID, they must go onto Ivermectin and its cocktail and must not be used in isolation.”
Aldous has stressed that Ivermectin is not a replacement for the COVID-19 vaccine at all.
Listen to the interview with Professor Colleen Aldous
0 Comments